Results from Kaneka Nutrients Europe study show interest in more education about Ubiquinol

In an August 19, 2025, press release, Kaneka Nutrients Europe announced results from a United Kingdom (UK) survey regarding consumer awareness of Ubiquinol. The nutrient, the bioactive form of CoenzymeQ10, plays an important role in reproductive health, it explained, and the results from the survey could create an opportunity for consumer education. The survey collected responses from more than 1000 men and women, ages 18-60, and was conducted with the collaboration of public health nutritionist Dr. Emma Derbyshire, who presented findings at the 2025 The Royal College of Obstetricians and Gynaecologists World Congress¹.

“While the science behind Ubiquinol in fertility is robust and expanding, what really resonates with me is seeing how eager people are to learn about it,” stated Dr. Derbyshire, in the press release. “Fertility struggles are deeply personal and can often feel overwhelming and isolating. Giving people evidence-based nutritional insights and guidance can help to empower them on their journey. Every person deserves to understand how nutrition might support their path to parenthood.”

Highlighted results from the survey include:

• 64% were not aware of the role of Ubiquinol in reproductive health
• 51% of respondents stated an interest in learning about Ubiquinol in the future
• 44% stated they would discuss with their General Practitioner to learn more about Ubiquinol, and 37% indicated that they would look online for more information

“These final findings present a roadmap for supplement brands developing consumer education strategies,” stated Filip Van hulle, general manager of Kaneka Nutrients Europe, in the press release. “Informative, engaging, and empathetic online content will play a major role, as will partnerships and collaborations with healthcare providers. In such a personal and private health area, real human connections paired with strong scientific backing are needed to win the day.”

Also noted were the declining fertility rates across Western and Central Europe^2,3, plus the projected 7.3% compound annual growth rate from 2024 to 2023 for Europe’s fertility market supplements⁴.

“With growing demand for reproductive health supplements across Europe, this new survey reveals there is also widespread consumer appetite for education on how nutrition can impact fertility journeys,” explained Van hulle. “This presents exciting opportunities for supplement manufacturers to fill these knowledge gaps and develop crucial connections with consumers in a health area that holds so much emotion. Kaneka Ubiquinol™ is a great place to start this education, as the ingredient has substantial scientific backing for its role in both female and male fertility, as well as growing support from healthcare professionals and experts like Dr Emma Derbyshire.”

In June 2025, Kaneka Nutrients announced the launch of a campaign to combat counterfeit ubiquinol products and misleading claims, partnering with laboratories for market surveillance and testing.

References

1. Derbyshire, Emma. “Awareness of Fertility Nutrient Ubiquinol: Findings from a UK Wide Population Survey.” Presentation at The Royal College of Obstetricians and Gynaecologists World Congress, 2025
2. The Office for National Statistics. “Births in England and Wales: 2023” https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/livebirths/bulletins/birthsummarytablesenglandandwales/2023 (accessed 2025-08-20).
3. National Records of Scotland. “Vital Events Reference Tables 2023” https://www.nrscotland.gov.uk/publications/vital-events-reference-tables-2023/ (accessed 2025-08-20).
4. Grand View Research. “Europe Fertility Supplements Market Size & Outlook.” https://www.grandviewresearch.com/horizon/outlook/fertility-supplements-market/europe (accessed 2025-08-20).